Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The safety of Covid-19 mRNA vaccines: a review
Pratibha Anand, Vincent P. Stahel
Patient Safety in Surgery (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

Chemistry, structure and function of approved oligonucleotide therapeutics
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 394
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 219
Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales
Mariam Alsanafi, Malik Sallam
Vaccines (2021) Vol. 9, Iss. 7, pp. 701-701
Open Access | Times Cited: 144
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 117
Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
Walid Al‐Qerem, Abdel Qader Al Bawab, Alaa M. Hammad, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 410-410
Open Access | Times Cited: 72
Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications
Yoseph Seo, Hayeon Lim, Hyunjun Park, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 772-772
Open Access | Times Cited: 71
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1192-1204
Closed Access | Times Cited: 71
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 56
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
Jiawei Zeng, Yao Li, Linrui Jiang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina
Milan Gautam, Antony Jozić, Grace Su, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 48
Microencapsulation for Pharmaceutical Applications: A Review
Cuie Yan, Sang-Ryoung Kim
ACS Applied Bio Materials (2024) Vol. 7, Iss. 2, pp. 692-710
Closed Access | Times Cited: 26
Administration of COVID-19 vaccines in immunocompromised patients
Manica Negahdaripour, Mojtaba Shafiekhani, Seyed Mohammad Iman Moezzi, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108021-108021
Open Access | Times Cited: 72
COVID-19 vaccine hesitancy among staff and students in a Nigerian tertiary educational institution
Ikemefuna C. Uzochukwu, George Uchenna Eleje, Chike Henry Nwankwo, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 71
Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 366-366
Open Access | Times Cited: 61
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination
Yair Zlotnik, Avi Gadoth, Ibrahim Abu‐Salameh, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 49
Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
Isaac Yeboah Addo, Frederick Dadzie, Sylvester Reuben Okeke, et al.
Archives of Public Health (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 47
Vaccine-Associated Uveitis after COVID-19 Vaccination
Rohan Bir Singh, Uday Pratap Singh Parmar, Francesca Kahale, et al.
Ophthalmology (2022) Vol. 130, Iss. 2, pp. 179-186
Open Access | Times Cited: 43
mRNA vaccine quality analysis using RNA sequencing
Helen M. Gunter, Senel Idrisoglu, Swati Singh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Karina Acevedo‐Whitehouse, Roxana Bruno
Medical Hypotheses (2023) Vol. 171, pp. 111015-111015
Open Access | Times Cited: 28
Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy
Ali Rafati, Yeganeh Pasebani, Melika Jameie, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 6, pp. 493-493
Open Access | Times Cited: 23
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants
Danyi Ao, Dandan Peng, Cai He, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
Edrous Alamer, Abdulaziz Alhazmi, Naaif A. Qasir, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1297-1297
Open Access | Times Cited: 53
Vaccine hesitancy: the greatest threat to COVID-19 vaccination programs
Samia A. Nossier
Journal of the Egyptian Public Health Association (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 50
Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
Mariapia Guerrieri, Beatrice Francavilla, Denise Fiorelli, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1499-1499
Open Access | Times Cited: 49
A review on the advances and challenges of immunotherapy for head and neck cancer
Gang Cheng, Hui Dong, Chen Yang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top